REDUCING THE EFFECT OF HUMAN PAPILLOMAVIRUS (HPV) IN ENUGU STATE: A CASE STUDY OF THE UNIVERSITY OF NIGERIA TEACHING HOSPITAL (UNTH)

Abstract

Human Papillomavirus (HPV) poses a significant public health challenge globally, with substantial implications for cervical cancer incidence. This study explores the prevalence and impact of HPV in Enugu State and at the University of Nigeria Teaching Hospital (UNTH). It evaluates the effectiveness of current HPV management strategies, including vaccination programs and cervical cancer screening, and identifies existing challenges. Through a detailed review of local and global data, the study highlights that despite ongoing efforts, HPV remains a critical health issue in the region. Key findings indicate a high prevalence of HPV, with existing interventions showing mixed results in their effectiveness. Challenges such as limited healthcare access, cultural barriers, and inadequate public awareness continue to hinder progress. The study's analysis suggests that strengthening vaccination programs, enhancing cervical cancer screening services, and increasing public education are crucial steps towards improving HPV management. The proposed policy changes and new intervention strategies aim to address these challenges by making prevention and treatment more accessible and effective. Furthermore, the study identifies several research gaps, including the need for a better understanding of barriers to HPV vaccination and the long-term outcomes of current interventions. In conclusion, the findings underscore the importance of a comprehensive approach to HPV management that includes policy reforms, community-based initiatives, and further research. Addressing these areas will be pivotal in reducing HPV-related disease burden and improving public health outcomes in Enugu State and similar regions. The study calls for continued commitment from policymakers, healthcare providers, and community leaders to tackle HPV effectively and enhance health outcomes.

1.1 Introduction

Human Papillomavirus (HPV) refers to a group of more than 200 related viruses, which are categorized into low-risk and high-risk types based on their potential to cause cancer. Low-risk HPVs are often associated with benign conditions such as warts, while high-risk types, notably HPV types 16 and 18, are linked to various cancers, including cervical, anal, and oropharyngeal cancers (Goldie et al., 2022). Globally, HPV infection is a major health concern, with HPV being the most common sexually transmitted infection worldwide. The World Health Organization (WHO) estimates that HPV is responsible for approximately 570,000 new cases of cervical cancer and 311,000 deaths annually, underscoring its global significance (World Health Organization, 2021).

In Nigeria, the burden of HPV-related diseases remains high. The prevalence of HPV infection among women is significant, with estimates suggesting that up to 30% of Nigerian women are infected with high-risk HPV types (Iliyasu et al., 2020). This prevalence contributes to the high incidence of cervical cancer, which is the second most common cancer among Nigerian women (Ojiyi et al., 2023). In Enugu State, the situation is particularly concerning. The region experiences a high rate of cervical cancer incidence and mortality, driven by inadequate screening and vaccination coverage. Reports indicate that while HPV vaccines are available, their uptake remains low due to various barriers, including lack of awareness and accessibility issues (Umeh et al., 2020).

1.2 Problem Statement

At the University of Nigeria Teaching Hospital (UNTH) in Enugu, the prevalence of HPV-related diseases is a pressing issue. Data from recent studies highlight a significant number of patients presenting with HPV-related conditions, particularly cervical cancer (Ezenwa et al., 2023). Despite the availability of HPV vaccines and screening programs, the uptake has been suboptimal. Factors contributing to this include insufficient public awareness, limited healthcare infrastructure, and socio-cultural barriers (Agida et al., 2023). The high prevalence of HPV and its related complications in Enugu State calls for urgent action to address these challenges and improve public health outcomes.

The management of HPV and its related diseases in Enugu State faces several challenges. One of the primary issues is the low awareness and acceptance of HPV vaccination among the general population and healthcare workers. Studies show that while there is knowledge about the HPV vaccine, there is a significant gap in the actual uptake and consistent use (Perlman et al., 2022). Additionally, the healthcare system in the region struggles with limited resources, which affects the implementation of effective screening and vaccination programs (Chigozie et al., 2021). Furthermore, socio-cultural beliefs and practices pose barriers to the acceptance of preventive measures. Addressing these challenges is crucial for reducing the incidence of HPV-related diseases and improving overall health outcomes in Enugu State.

1.3 Objectives of the Study

The primary objective of this study is to evaluate the current interventions for HPV prevention and management in Enugu State, with a particular focus on UNTH. This involves assessing the effectiveness of existing HPV vaccination and screening programs, identifying gaps in their implementation, and understanding the barriers to their success (Olowookere et al., 2017). The study aims to propose actionable strategies to enhance the uptake of HPV vaccination, improve screening rates, and address the socio-cultural and infrastructural barriers affecting HPV management. By identifying these gaps and proposing targeted interventions, the study seeks to contribute to better health outcomes for women in Enugu State and strengthen the overall healthcare system's response to HPV-related diseases.

1.4 Significance of the Study

This study is significant for several reasons. First, it provides valuable insights into the current state of HPV management and prevention in Enugu State, highlighting critical areas that need improvement (Vermandere et al., 2020). By identifying gaps and proposing strategies, the study aims to support public health initiatives in enhancing HPV vaccination coverage and screening programs. Improved management of HPV has the potential to reduce the incidence of cervical cancer and other HPV-related diseases, thereby improving the quality of life and health outcomes for women in the region (Jaspers et al., 2021). Additionally, the findings of this study can inform healthcare policies and contribute to the development of targeted interventions that address both the clinical and socio-cultural aspects of HPV management. This will ultimately benefit local communities and strengthen the healthcare system's ability to combat HPV-related diseases effectively.